ATE9846T1 - Radioimmunoassay fuer migration-inhibitionsfaktor. - Google Patents

Radioimmunoassay fuer migration-inhibitionsfaktor.

Info

Publication number
ATE9846T1
ATE9846T1 AT80301692T AT80301692T ATE9846T1 AT E9846 T1 ATE9846 T1 AT E9846T1 AT 80301692 T AT80301692 T AT 80301692T AT 80301692 T AT80301692 T AT 80301692T AT E9846 T1 ATE9846 T1 AT E9846T1
Authority
AT
Austria
Prior art keywords
mif
radioimmunoassay
antibodies
antigen
inhibition factor
Prior art date
Application number
AT80301692T
Other languages
English (en)
Inventor
Eva Jane Brandt
Samuel Simon Asculai
Original Assignee
Monsanto Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monsanto Company filed Critical Monsanto Company
Application granted granted Critical
Publication of ATE9846T1 publication Critical patent/ATE9846T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00—Preparation of derivatives of starch
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/212—Starch; Modified starch; Starch derivatives, e.g. esters or ethers
    • A23L29/219—Chemically modified starch; Reaction or complexation products of starch with other chemicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/804—Radioisotope, e.g. radioimmunoassay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Nutrition Science (AREA)
  • Dispersion Chemistry (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Optical Communication System (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT80301692T 1979-05-25 1980-05-22 Radioimmunoassay fuer migration-inhibitionsfaktor. ATE9846T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/042,662 US4299814A (en) 1979-05-25 1979-05-25 Radioimmunoassay of MIF
EP80301692A EP0020090B1 (de) 1979-05-25 1980-05-22 Radioimmunoassay für Migration-Inhibitions-Faktor

Publications (1)

Publication Number Publication Date
ATE9846T1 true ATE9846T1 (de) 1984-10-15

Family

ID=21923107

Family Applications (1)

Application Number Title Priority Date Filing Date
AT80301692T ATE9846T1 (de) 1979-05-25 1980-05-22 Radioimmunoassay fuer migration-inhibitionsfaktor.

Country Status (6)

Country Link
US (1) US4299814A (de)
EP (1) EP0020090B1 (de)
JP (1) JPS55158560A (de)
KR (1) KR830002333A (de)
AT (1) ATE9846T1 (de)
DE (1) DE3069404D1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI800724A (fi) * 1979-03-15 1980-09-16 Ciba Geigy Ag Diagnosfoerfarande och utrustning foer att genomfoera detsamma
JPH0672158B2 (ja) * 1984-05-24 1994-09-14 チバ−ガイギ− アクチエンゲゼルシヤフト 精製されたヒトマクロファージ遊走阻止因子
US6774227B1 (en) * 1993-05-17 2004-08-10 Cytokine Pharmasciences, Inc. Therapeutic uses of factors which inhibit or neutralize MIF activity
US6080407A (en) * 1993-05-17 2000-06-27 The Picower Institute For Medical Research Diagnostic assays for MIF
MY140679A (en) * 2001-05-24 2010-01-15 Avanir Pharmaceuticals Inhibitors of macrohage migration inhibitory factor and methods for identifying the same
WO2003047622A1 (fr) * 2001-11-30 2003-06-12 Jun Nishihira Remedes pour la sclerose en plaques
KR100530611B1 (ko) * 2002-11-22 2005-11-22 한국원자력연구소 대식세포 유주저지인자의 농도 측정을 위한 방사면역측정법
TW200418829A (en) * 2003-02-14 2004-10-01 Avanir Pharmaceutics Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
BRPI0413695A (pt) * 2003-08-22 2006-10-24 Avanir Pharmaceuticals derivados de naftiridina substituìda como inibidores do fator inibidor da migração de macrófagos e seu uso no tratamento de doenças humanas
EP1745194A4 (de) * 2004-02-25 2008-02-06 Us Dept Veterans Affairs Verfahren zur diagnose und behandlung von blasenkrebs
CA2600175A1 (en) * 2005-03-24 2006-03-20 Avanir Pharmaceuticals Thienopyridinone derivatives as macrophage migration inhibitory factor inhibitors
GB0605689D0 (en) * 2006-03-21 2006-05-03 Novartis Ag Organic compounds
JP2014530360A (ja) 2011-10-07 2014-11-17 バクスター・ヘルスケヤー・ソシエテ・アノニムＢａｘｔｅｒ Ｈｅａｌｔｈｃａｒｅ ＳＡ 診断マーカーとしてのｏｘＭＩＦ

Also Published As

Publication number Publication date
JPS55158560A (en) 1980-12-10
KR830002333A (ko) 1983-05-28
JPS6259783B2 (de) 1987-12-12
DE3069404D1 (en) 1984-11-15
EP0020090B1 (de) 1984-10-10
EP0020090A1 (de) 1980-12-10
US4299814A (en) 1981-11-10

Similar Documents

Publication Publication Date Title
Vandvik et al. Oligoclonal IgG antibody response in the central nervous system to different measles virus antigens in subacute sclerosing panencephalitis
CA1270194A (en) Method for enhancing and/or accelerating immunoassay detection of human carcinoma tumor associated antigen in a pathology sample
ATE9846T1 (de) Radioimmunoassay fuer migration-inhibitionsfaktor.
DK158284A (da) Monoklonale antistoffer afledt af tvaerbundne fibrinderivater samt analysemetode til bestemmelse af disse derivater
ATE66531T1 (de) Verfahren zum nachweis von immunkomplexen im serum.
SE8102558L (sv) Immunologisk bestemmningsmetod
ATE15945T1 (de) Verfahren zum nachweis von haemoglobin in faezes.
ATE81406T1 (de) Verfahren zum nachweis von antigenen und/oder antikoerpern sowie testausruestung zur durchfuehrung des verfahrens.
ATE75041T1 (de) Verfahren und vorrichtung zur messung des reaktionsgrades zwischen antigenen und zellleukozytenantik¯rpern.
Page et al. Immunologic studies in normal human sweat
ES2033823T3 (es) Ensayo en cuanto a cancer de mama humano.
SE8004542L (sv) Diagnostiskt test
FR2307270A1 (fr) Procede de determination quantitative d'une substance antigene et ensemble de diagnostic destine a la mise en oeuvre de ce procede
ATE67315T1 (de) Verfahren zur durchfuehrung von immunfluoreszenztesten.
SE8205891D0 (sv) Alfa-l-antikropp och sett for framstellning derav
Milgrom et al. Studies on species specificity
Symons et al. Stimulation of pig lymphocytes with anti-immunoglobulin serum and mitogens
Myers et al. Serodiagnosis of ram epididymitis by counterimmunoelectrophoresis, using Brucella ovis surface R antigen
ES8705232A1 (es) Un metodo para preparar un anticuerpo monoclonal destinado autilizarse como auxiliar de diagnostico para detectar cancerde pulmon
GB1413799A (en) Serological reagent
SU712091A1 (ru) Способ определени антигена или антител е вируса гепатита в
ATE14799T1 (de) Verfahren zur feststellung sehr geringer antigen- und antikoerpermengen nach einem agglutinations- hemmungstest.
EP0219279A3 (de) Reagenz zum Nachweis und zur Messung der Acetaldehydprotein-Kondensationsprodukte in einer Flüssigkeit, zusammen mit seiner Herstellung und seinem Verwendungsverfahren
JPS5535247A (en) Reagent for h-lysozyme measurement
JPS56125667A (en) Reagent for measurement and measuring method for human muscle type aldolase

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee